Showing results (71-80 of 430) with videos related to

Sort By:
Pageof 43
Journal of the American College of Cardiology|May 16, 2006
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programLars G Olsson, Karl Swedberg, Anique Ducharme, et al.
Circulation. Cardiovascular Quality and Outcomes|March 18, 2010
Cognitive function and anticoagulation control in patients with atrial fibrillationGreg C Flaker, Janice Pogue, Salim Yusuf, et al.
Lancet (London, England)|December 13, 2005
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialBradi B Granger, Karl Swedberg, Inger Ekman, et al.
European Journal of Heart Failure|September 6, 2017
Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortalityElke Platz, Pardeep S Jhund, Brian L Claggett, et al.
Journal of Cardiac Failure|March 14, 2013
Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRTDorit Knappe, Anne-Catherine Pouleur, Amil M Shah, et al.
JACC. Heart Failure|October 17, 2017
Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT StudyAli Vazir, Brian Claggett, Bertram Pitt, et al.
Stroke|March 8, 2008
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)Jeff S Healey, Robert G Hart, Janice Pogue, et al.
Circulation|December 20, 2011
Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary diseaseMarc S Sabatine, David A Morrow, James A de Lemos, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 22, 2020
Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipientsAugustine W Kang, Andrew G Bostom, Hongseok Kim, et al.
Journal of the American Heart Association|June 30, 2016
Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial InfarctionRenato D Lopes, Karen S Pieper, Susanna R Stevens, et al.
Pageof 43